Leptin suppression of insulin secretion and gene expression in human pancreatic islets: Implications for the development of adipogenic diabetes mellitus
J. Seufert et al., Leptin suppression of insulin secretion and gene expression in human pancreatic islets: Implications for the development of adipogenic diabetes mellitus, J CLIN END, 84(2), 1999, pp. 670-676
Previously we demonstrated the expression of the long form of the leptin re
ceptor in rodent pancreatic beta-cells and an inhibition of insulin secreti
on by leptin via activation of ATP-sensitive potassium channels. Here we ex
amine pancreatic islets isolated from pancreata of human donors for their r
esponses to leptin. The presence of leptin receptors on islet beta-cells wa
s demonstrated by double fluorescence confocal microscopy after binding of
a fluorescent derivative of human leptin (Cy3-leptin). Leptin (6.25 nM) sup
pressed insulin secretion of normal islets by 20% at 5.6 mM glucose. Intrac
ellular calcium responses to 16.7 mM glucose were rapidly reduced by leptin
. Proinsulin messenger ribonucleic acid expression in islets was inhibited
by leptin at 11.1 mM, but not at 5.6 mM glucose. Leptin also reduced proins
ulin messenger ribonucleic acid levels that were increased in islets by tre
atment with 10 nM glucagon-like peptide-1 in the presence of either 5.6 or
11.1 mM glucose. These findings demonstrate direct suppressive effects of l
eptin on insulin-producing beta-cells in human islets at the levels of both
stimulus-secretion coupling and gene expression. The findings also further
indicate the existence of an adipoinsular axis in humans in which insulin
stimulates leptin production in adipocytes and leptin inhibits the producti
on of insulin in beta-cells. We suggest that dysregulation of the adipoinsu
lar axis in obese individuals due to defective leptin reception by beta-cel
ls may result in chronic hyperinsulinemia and may contribute to the pathoge
nesis of adipogenic diabetes.